2026-2032 Global Clinical Risk Grouping Solutions Industry Research & Trends Analysis Report- YH Research

Home > Reports >Medical Care > 2026-2032 Global Clinical Risk Grouping Solutions Industry Research & Trends Analysis Report

2026-2032 Global Clinical Risk Grouping Solutions Industry Research & Trends Analysis Report

Publication Date: 2026-07-05
Report Id: 3135483
Industry: Medical Care
Report Page: 145
Chart: 141

PDF Download

Publication Date: 2026-07-05
Report Id: 3135483
Industry: Medical Care
Report Page: 145
Chart: 141

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of Clinical Risk Grouping Solutions
1.2 Global Clinical Risk Grouping Solutions Market Size and Forecast
1.3 China Clinical Risk Grouping Solutions Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Clinical Risk Grouping Solutions Share in Global Market, 2021-2032
1.4.2 Clinical Risk Grouping Solutions Market Size: China VS Global, 2021-2032
1.5 Clinical Risk Grouping Solutions Market Dynamics
1.5.1 Clinical Risk Grouping Solutions Market Drivers
1.5.2 Clinical Risk Grouping Solutions Market Restraints
1.5.3 Clinical Risk Grouping Solutions Industry Trends
1.5.4 Clinical Risk Grouping Solutions Industry Policy

2 Competitive Landscape by Company
2.1 Global Clinical Risk Grouping Solutions Revenue by Company, 2021-2026
2.2 Global Clinical Risk Grouping Solutions Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Clinical Risk Grouping Solutions Concentration Ratio
2.4 Global Clinical Risk Grouping Solutions Mergers & Acquisitions, Expansion Plans
2.5 Global Clinical Risk Grouping Solutions Manufacturers Product Type
2.6 Global Geographic Distribution of Clinical Risk Grouping Solutions Companies

3 China Competitive Situation by Company
3.1 China Clinical Risk Grouping Solutions Revenue by Company, 2021-2026
3.2 China Clinical Risk Grouping Solutions Clinical Risk Grouping Solutions Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Clinical Risk Grouping Solutions Market, Revenue Percentage of Local Players VS Foreign Players (2021-2032)

4 Industry Chain Analysis
4.1 Clinical Risk Grouping Solutions Industry Chain
4.2 Clinical Risk Grouping Solutions Upstream Analysis
4.3 Clinical Risk Grouping Solutions Midstream Analysis
4.4 Clinical Risk Grouping Solutions Downstream Analysis

5 Sights by Type
5.1 Clinical Risk Grouping Solutions Classification by Type
5.1.1 Scorecard and Visualization Tools
5.1.2 Dashboard Analysis
5.1.3 Risk Report
5.2 by Type, Global Clinical Risk Grouping Solutions Market Size & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global Clinical Risk Grouping Solutions Market Size, 2021-2032

6 Sights by Technology
6.1 Clinical Risk Grouping Solutions Classification by Technology
6.1.1 Rule-based Risk Models
6.1.2 Statistical Risk Models
6.1.3 Machine Learning Risk Models
6.1.4 AI Deep Learning Risk Models
6.2 by Technology, Global Clinical Risk Grouping Solutions Market Size & CAGR, 2021 VS 2025 VS 2032
6.3 by Technology, Global Clinical Risk Grouping Solutions Market Size, 2021-2032

7 Sights by Risk Group
7.1 Clinical Risk Grouping Solutions Classification by Risk Group
7.1.1 Low-Risk Group: Readmission Rate <5%
7.1.2 Medium-Risk Group: Readmission Rate 5%–15%
7.1.3 High-Risk Group: Readmission Rate >15%
7.2 by Risk Group, Global Clinical Risk Grouping Solutions Market Size & CAGR, 2021 VS 2025 VS 2032
7.3 by Risk Group, Global Clinical Risk Grouping Solutions Market Size, 2021-2032

8 Sights by Application
8.1 Clinical Risk Grouping Solutions Segment by Application
8.1.1 Hospital
8.1.2 Nursing Center
8.1.3 Other
8.2 by Application, Global Clinical Risk Grouping Solutions Market Size & CAGR, 2021 VS 2025 VS 2032
8.3 by Application, Global Clinical Risk Grouping Solutions Market Size, 2021-2032

9 Sights by Region
9.1 By Region, Global Clinical Risk Grouping Solutions Market Size, 2021 VS 2025 VS 2032
9.2 By Region, Global Clinical Risk Grouping Solutions Market Size, 2021-2032
9.3 North America
9.3.1 North America Clinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
9.3.2 By Country, North America Clinical Risk Grouping Solutions Market Size Market Share
9.4 Europe
9.4.1 Europe Clinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
9.4.2 By Country, Europe Clinical Risk Grouping Solutions Market Size Market Share
9.5 Asia Pacific
9.5.1 Asia Pacific Clinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
9.5.2 By Country/Region, Asia Pacific Clinical Risk Grouping Solutions Market Size Market Share
9.6 South America
9.6.1 South America Clinical Risk Grouping Solutions Market Size & Forecasts, 2021-2032
9.6.2 By Country, South America Clinical Risk Grouping Solutions Market Size Market Share
9.7 Middle East & Africa

10 Sights by Country Level
10.1 By Country, Global Clinical Risk Grouping Solutions Market Size & CAGR，2021 VS 2025 VS 2032
10.2 By Country, Global Clinical Risk Grouping Solutions Market Size, 2021-2032
10.3 United States
10.3.1 United States Clinical Risk Grouping Solutions Market Size, 2021-2032
10.3.2 By Company, United States Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.3.3 by Type, United States Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.3.4 by Application, United States Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.4 Europe
10.4.1 Europe Clinical Risk Grouping Solutions Market Size, 2021-2032
10.4.2 By Company, Europe Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.4.3 by Type, Europe Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.4.4 by Application, Europe Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.5 China
10.5.1 China Clinical Risk Grouping Solutions Market Size, 2021-2032
10.5.2 By Company, China Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.5.3 by Type, China Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.5.4 by Application, China Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.6 Japan
10.6.1 Japan Clinical Risk Grouping Solutions Market Size, 2021-2032
10.6.2 By Company, Japan Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.6.3 by Type, Japan Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.6.4 by Application, Japan Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.7 South Korea
10.7.1 South Korea Clinical Risk Grouping Solutions Market Size, 2021-2032
10.7.2 By Company, South Korea Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.7.3 by Type, South Korea Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.7.4 by Application, South Korea Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.8 Southeast Asia
10.8.1 Southeast Asia Clinical Risk Grouping Solutions Market Size, 2021-2032
10.8.2 By Company, Southeast Asia Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.8.3 by Type, Southeast Asia Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.8.4 by Application, Southeast Asia Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.9 India
10.9.1 India Clinical Risk Grouping Solutions Market Size, 2021-2032
10.9.2 By Company, India Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.9.3 by Type, India Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.9.4 by Application, India Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.10 Middle East & Africa
10.10.1 Middle East & Africa Clinical Risk Grouping Solutions Market Size, 2021-2032
10.10.2 By Company, Middle East & Africa Clinical Risk Grouping Solutions Revenue Market Share, 2025
10.10.3 by Type, Middle East & Africa Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032
10.10.4 by Application, Middle East & Africa Clinical Risk Grouping Solutions Revenue Market Share, 2025 VS 2032

11 Company Profile
11.1 3M Corporation
11.1.1 3M Corporation Company Information, Head Office, Market Area, and Industry Position
11.1.2 3M Corporation Company Profile and Main Business
11.1.3 3M Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
11.1.4 3M Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.1.5 3M Corporation Recent Developments
11.2 Cerner Corporation
11.2.1 Cerner Corporation Company Information, Head Office, Market Area, and Industry Position
11.2.2 Cerner Corporation Company Profile and Main Business
11.2.3 Cerner Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
11.2.4 Cerner Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.2.5 Cerner Corporation Recent Developments
11.3 Optum (UnitedHealth Group)
11.3.1 Optum (UnitedHealth Group) Company Information, Head Office, Market Area, and Industry Position
11.3.2 Optum (UnitedHealth Group) Company Profile and Main Business
11.3.3 Optum (UnitedHealth Group) Clinical Risk Grouping Solutions Models, Specifications, and Application
11.3.4 Optum (UnitedHealth Group) Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.3.5 Optum (UnitedHealth Group) Recent Developments
11.4 Epic Systems Corporation
11.4.1 Epic Systems Corporation Company Information, Head Office, Market Area, and Industry Position
11.4.2 Epic Systems Corporation Company Profile and Main Business
11.4.3 Epic Systems Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
11.4.4 Epic Systems Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.4.5 Epic Systems Corporation Recent Developments
11.5 Oracle Cerner
11.5.1 Oracle Cerner Company Information, Head Office, Market Area, and Industry Position
11.5.2 Oracle Cerner Company Profile and Main Business
11.5.3 Oracle Cerner Clinical Risk Grouping Solutions Models, Specifications, and Application
11.5.4 Oracle Cerner Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.5.5 Oracle Cerner Recent Developments
11.6 IBM Corporation
11.6.1 IBM Corporation Company Information, Head Office, Market Area, and Industry Position
11.6.2 IBM Corporation Company Profile and Main Business
11.6.3 IBM Corporation Clinical Risk Grouping Solutions Models, Specifications, and Application
11.6.4 IBM Corporation Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.6.5 IBM Corporation Recent Developments
11.7 SAS Institute Inc.
11.7.1 SAS Institute Inc. Company Information, Head Office, Market Area, and Industry Position
11.7.2 SAS Institute Inc. Company Profile and Main Business
11.7.3 SAS Institute Inc. Clinical Risk Grouping Solutions Models, Specifications, and Application
11.7.4 SAS Institute Inc. Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.7.5 SAS Institute Inc. Recent Developments
11.8 Veradigm (Allscripts)
11.8.1 Veradigm (Allscripts) Company Information, Head Office, Market Area, and Industry Position
11.8.2 Veradigm (Allscripts) Company Profile and Main Business
11.8.3 Veradigm (Allscripts) Clinical Risk Grouping Solutions Models, Specifications, and Application
11.8.4 Veradigm (Allscripts) Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.8.5 Veradigm (Allscripts) Recent Developments
11.9 Health Catalyst
11.9.1 Health Catalyst Company Information, Head Office, Market Area, and Industry Position
11.9.2 Health Catalyst Company Profile and Main Business
11.9.3 Health Catalyst Clinical Risk Grouping Solutions Models, Specifications, and Application
11.9.4 Health Catalyst Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.9.5 Health Catalyst Recent Developments
11.10 Cotiviti
11.10.1 Cotiviti Company Information, Head Office, Market Area, and Industry Position
11.10.2 Cotiviti Company Profile and Main Business
11.10.3 Cotiviti Clinical Risk Grouping Solutions Models, Specifications, and Application
11.10.4 Cotiviti Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.10.5 Cotiviti Recent Developments
11.11 IQVIA
11.11.1 IQVIA Company Information, Head Office, Market Area, and Industry Position
11.11.2 IQVIA Company Profile and Main Business
11.11.3 IQVIA Clinical Risk Grouping Solutions Models, Specifications, and Application
11.11.4 IQVIA Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.11.5 IQVIA Recent Developments
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Information, Head Office, Market Area, and Industry Position
11.12.2 Siemens Healthineers Company Profile and Main Business
11.12.3 Siemens Healthineers Clinical Risk Grouping Solutions Models, Specifications, and Application
11.12.4 Siemens Healthineers Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.12.5 Siemens Healthineers Recent Developments
11.13 Philips Healthcare
11.13.1 Philips Healthcare Company Information, Head Office, Market Area, and Industry Position
11.13.2 Philips Healthcare Company Profile and Main Business
11.13.3 Philips Healthcare Clinical Risk Grouping Solutions Models, Specifications, and Application
11.13.4 Philips Healthcare Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.13.5 Philips Healthcare Recent Developments
11.14 Dedalus
11.14.1 Dedalus Company Information, Head Office, Market Area, and Industry Position
11.14.2 Dedalus Company Profile and Main Business
11.14.3 Dedalus Clinical Risk Grouping Solutions Models, Specifications, and Application
11.14.4 Dedalus Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.14.5 Dedalus Recent Developments
11.15 Change Healthcare
11.15.1 Change Healthcare Company Information, Head Office, Market Area, and Industry Position
11.15.2 Change Healthcare Company Profile and Main Business
11.15.3 Change Healthcare Clinical Risk Grouping Solutions Models, Specifications, and Application
11.15.4 Change Healthcare Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.15.5 Change Healthcare Recent Developments
11.16 Yidu Tech
11.16.1 Yidu Tech Company Information, Head Office, Market Area, and Industry Position
11.16.2 Yidu Tech Company Profile and Main Business
11.16.3 Yidu Tech Clinical Risk Grouping Solutions Models, Specifications, and Application
11.16.4 Yidu Tech Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.16.5 Yidu Tech Recent Developments
11.17 Ping An Healthcare
11.17.1 Ping An Healthcare Company Information, Head Office, Market Area, and Industry Position
11.17.2 Ping An Healthcare Company Profile and Main Business
11.17.3 Ping An Healthcare Clinical Risk Grouping Solutions Models, Specifications, and Application
11.17.4 Ping An Healthcare Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.17.5 Ping An Healthcare Recent Developments
11.18 Toshiba
11.18.1 Toshiba Company Information, Head Office, Market Area, and Industry Position
11.18.2 Toshiba Company Profile and Main Business
11.18.3 Toshiba Clinical Risk Grouping Solutions Models, Specifications, and Application
11.18.4 Toshiba Clinical Risk Grouping Solutions Revenue and Gross Margin, 2021-2026
11.18.5 Toshiba Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for Clinical Risk Grouping Solutions should grow from US$ 706 million in 2025 to US$ 1115 million by 2032, with a CAGR of 6.7% for the period of 2026-2032.

Clinical Risk Grouping Solutions are analytical systems that utilize artificial intelligence, machine learning, statistical modeling, and clinical rule frameworks to stratify patient populations by health risk, predict disease risks, and optimize the allocation of medical resources. By integrating electronic medical records (EMR), laboratory and imaging data, medication records, genetic information, and health behavior data, these solutions assign risk scores and manage patients within specific categories—such as low, medium, high, and very high-risk groups. Their primary objective is to enable healthcare institutions to implement precision medical management, stratified chronic disease care, inpatient risk prediction, readmission risk control, and cost optimization. Consequently, they enhance care quality, reduce costs, and optimize resource allocation, finding widespread application in hospital administration, insurance payment management, public health, and health management.

Clinical Risk Grouping Solutions

According to YH Research, the global market for Clinical Risk Grouping Solutions should grow from US$ 706 million in 2025 to US$ 1115 million by 2032, with a CAGR of 6.7% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The global landscape for clinical risk grouping solutions is characterized by North American leadership, standardized advancement in Europe, and rapid growth in the Asia-Pacific region. The North American market is primarily driven by insurance payment systems and value-based care models, with applications focused on chronic disease management, readmission risk prediction, cost containment, and population health management. The European market emphasizes regulatory compliance, data privacy protection, and the optimization of public healthcare system efficiency. Meanwhile, the Asia-Pacific region is experiencing surging demand fueled by aging populations, the rising burden of chronic diseases, and the digital transformation of healthcare. The market is currently transitioning from traditional rule-based risk stratification to AI-driven dynamic risk prediction and real-time population health management; clients increasingly prioritize prediction accuracy, clinical interpretability, data integration capabilities, and the optimization of payment efficiency. Future trends include real-time AI risk scoring, clinical risk prediction based on large-scale models, multimodal health data fusion, personalized health intervention recommendations, and integration with health insurance payment models. Key challenges include a lack of unified medical data standards, difficulties in cross-institutional data sharing, insufficient model interpretability, lengthy clinical validation cycles, and strict privacy compliance regulations. The industry's average gross margin typically ranges from 50% to 75%; standardized SaaS-based risk grouping platforms generally command higher margins, whereas customized system integration and clinical implementation projects yield relatively lower margins.

This report aims to provide a comprehensive study of the global market for Clinical Risk Grouping Solutions. Report Highlights:
(1) Global Clinical Risk Grouping Solutions market size (value), history data from 2021-2025, and forecast data from 2026 to 2032.

(2) Global Clinical Risk Grouping Solutions market competitive situation, revenue, and market share, from 2021 to 2025.

(3) China Clinical Risk Grouping Solutions market competitive situation, revenue, and market share, from 2021 to 2025.

(4) Global Clinical Risk Grouping Solutions segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Clinical Risk Grouping Solutions segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Clinical Risk Grouping Solutions industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Scorecard and Visualization Tools
    Dashboard Analysis
    Risk Report

Market segment by Technology, covers
    Rule-based Risk Models
    Statistical Risk Models
    Machine Learning Risk Models
    AI Deep Learning Risk Models

Market segment by Risk Group, covers
    Low-Risk Group: Readmission Rate <5%
    Medium-Risk Group: Readmission Rate 5%–15%
    High-Risk Group: Readmission Rate >15%

Market segment by Application, can be divided into
    Hospital
    Nursing Center
    Other

Market segment by players, this report covers
    3M Corporation
    Cerner Corporation
    Optum (UnitedHealth Group)
    Epic Systems Corporation
    Oracle Cerner
    IBM Corporation
    SAS Institute Inc.
    Veradigm (Allscripts)
    Health Catalyst
    Cotiviti
    IQVIA
    Siemens Healthineers
    Philips Healthcare
    Dedalus
    Change Healthcare
    Yidu Tech
    Ping An Healthcare
    Toshiba